High-fat diets rich in saturated fat protect against Azoxymethane/Dextran sulfate sodium-induced colon cancer

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 310, Issue 11, 2016, Pages G906-G919

  Enos, Reilly T ^a   Velázquez, Kandy T ^a   McClellan, Jamie L ^a   Cranford, Taryn L ^a   Nagarkatti, Mitzi ^a   Nagarkatti, Prakash S ^a   Davis, J Mark ^b   Murphy, E Angela ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

High fat diet; Inflammation; Mucin 2

Indexed keywords

AZOXYMETHANE; COCONUT OIL; DEXTRAN SULFATE; GLUCOSE; INSULIN; INTERLEUKIN 10; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; MUCIN 2; MUCIN 5AC; MUCIN 6; OCCLUDIN; PROTEIN ZO1; SATURATED FATTY ACID; STAT3 PROTEIN; TUMOR NECROSIS FACTOR; DODECYL SULFATE SODIUM; FAT INTAKE; FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD SAMPLING; BODY COMPOSITION; CALORIC INTAKE; CANCER GROWTH; CANCER PREVENTION; CANCER RISK; CELL PROLIFERATION; COLON CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; DUAL ENERGY X RAY ABSORPTIOMETRY; EPIDIDYMIS FAT; FEMALE; GENE EXPRESSION; GLUCOSE METABOLISM; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; LIPID COMPOSITION; LIPID DIET; MALE; MOLECULAR WEIGHT; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; TUMOR VOLUME; WESTERN BLOTTING; WESTERN DIET; ANIMAL; C57BL MOUSE; COLONIC NEOPLASMS; DIET THERAPY; FAT INTAKE; THERAPEUTIC USE;

ANIMALS; APOPTOSIS; AZOXYMETHANE; CELL PROLIFERATION; COLONIC NEOPLASMS; DIET, HIGH-FAT; DIETARY FATS; FATTY ACIDS; FEMALE; MALE; MICE; MICE, INBRED C57BL; SODIUM DODECYL SULFATE;

EID: 84984644975     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00345.2015     Document Type: Article

References (49)

1. Aleksandrova K, Nimptsch K, Pischon T. Obesity and colorectal cancer. Front Biosci (Elite Ed) 5: 61–77, 2013.
2. Barzi A, Lenz AM, Labonte MJ, Lenz HJ. Molecular pathways: estrogen pathway in colorectal cancer. Clin Cancer Res 19: 5842–5848, 2013.
3. Benoit B, Bruno J, Kayal F, Estienne M, Debard C, Ducroc R, Plaisancie P. Saturated and unsaturated fatty acids differently modulate colonic goblet cells in vitro and in rat pups. J Nutr 145: 1754–1762, 2015.
4. Bissahoyo A, Pearsall RS, Hanlon K, Amann V, Hicks D, Godfrey VL, Threadgill DW. Azoxymethane is a genetic background-dependent colorectal tumor initiator and promoter in mice: effects of dose, route, and diet. Toxicol Sci 88: 340–345, 2005.
5. Boddicker RL, Whitley E, Birt DF, Spurlock ME. Early lesion formation in colorectal carcinogenesis is associated with adiponectin status whereas neoplastic lesions are associated with diet and sex in C57BL/6J mice. Nutr Cancer 63: 1297–1306, 2011.
6. Bu SY, Kwon H, Sung MK. Supplementation of seaweeds extracts suppresses azoxymethane-induced aberrant DNA methylation in colon and liver of ICR mice. J Cancer Prev 19: 216–223, 2014.
7. Carson JA, Lee WJ, McClung J, Hand GA. Steroid receptor concentration in aged rat hindlimb muscle: effect of anabolic steroid administration. J Appl Physiol 93: 242–250, 2002.
8. Chen J, Huang XF. The signal pathways in azoxymethane-induced colon cancer and preventive implications. Cancer Biol Ther 8: 1313–1317, 2009.
9. Clapper ML, Cooper HS, Chang WC. Dextran sulfate sodium-induced colitis-associated neoplasia: a promising model for the development of chemopreventive interventions. Acta Pharmacol Sin 28: 1450–1459, 2007.
10. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69: 238–249, 1993.
11. Cross AJ, Pollock JR, Bingham SA. Haem, not protein or inorganic iron, is responsible for endogenous intestinal N-nitrosation arising from red meat. Cancer Res 63: 2358–2360, 2003.
12. Day SD, Enos RT, McClellan JL, Steiner JL, Velazquez KT, Murphy EA. Linking inflammation to tumorigenesis in a mouse model of highfat-diet-enhanced colon cancer. Cytokine 64: 454–462, 2013.
13. Enos RT, Davis JM, Velazquez KT, McClellan JL, Day SD, Carnevale KA, Murphy EA. Influence of dietary saturated fat content on adiposity, macrophage behavior, inflammation, and metabolism: composition matters. J Lipid Res 54: 152–163, 2013.
14. Enos RT, Velazquez KT, McClellan JL, Cranford TL, Walla MD, Murphy EA. Lowering the dietary omega-6: omega-3 does not hinder nonalcoholic fatty-liver disease development in a murine model. Nutr Res 35: 449–459, 2015.
15. Enos RT, Velazquez KT, Murphy EA. Insight into the impact of dietary saturated fat on tissue-specific cellular processes underlying obesityrelated diseases. J Nutr Biochem 25: 600–612, 2014.
16. Fang JY, Richardson BC. The MAPK signalling pathways and colorectal cancer. Lancet Oncol 6: 322–327, 2005.
17. Gabele E, Dostert K, Hofmann C, Wiest R, Scholmerich J, Hellerbrand C, Obermeier F. DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH. J Hepatol 55: 1391–1399, 2011.
18. Goncalves P, Martel F. Butyrate and colorectal cancer: the role of butyrate transport. Curr Drug Metab 14: 994–1008, 2013.
19. Grotto D, Zied E. The Standard American Diet and its relationship to the health status of Americans. Nutr Clin Pract 25: 603–612, 2010.
20. Gupta J, del Barco Barrantes I, Igea A, Sakellariou S, Pateras IS, Gorgoulis VG, Nebreda AR. Dual function of p38alpha MAPK in colon cancer: suppression of colitis-associated tumor initiation but requirement for cancer cell survival. Cancer Cell 25: 484–500, 2014.
21. Gupta J, Nebreda AR. Roles of p38alpha mitogen-activated protein kinase in mouse models of inflammatory diseases and cancer. FEBS J 282: 1841–1857, 2015.
22. Haggar FA, Boushey RP. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 22: 191–197, 2009.
23. Irizar A, Barnett CR, Flatt PR, Ioannides C. Defective expression of cytochrome P450 proteins in the liver of the genetically obese Zucker rat. Eur J Pharmacol 293: 385–393, 1995.
24. Johnson AW. Dietary manipulations influence sucrose acceptance in diet induced obese mice. Appetite 58: 215–221, 2012.
25. Joosen AM, Kuhnle GG, Aspinall SM, Barrow TM, Lecommandeur E, Azqueta A, Collins AR, Bingham SA. Effect of processed and red meat on endogenous nitrosation and DNA damage. Carcinogenesis 30: 1402–1407, 2009.
26. Kirpich IA, Feng W, Wang Y, Liu Y, Barker DF, Barve SS, McClain CJ. The type of dietary fat modulates intestinal tight junction integrity, gut permeability, and hepatic toll-like receptor expression in a mouse model of alcoholic liver disease. Alcohol Clin Exp Res 36: 835–846, 2012.
27. Laroui H, Ingersoll SA, Liu HC, Baker MT, Ayyadurai S, Charania MA, Laroui F, Yan Y, Sitaraman SV, Merlin D. Dextran sodium sulfate (DSS) induces colitis in mice by forming nano-lipocomplexes with medium-chain-length fatty acids in the colon. PLoS One 7: e32084, 2012.
28. Louie SM, Roberts LS, Nomura DK. Mechanisms linking obesity and cancer. Biochim Biophys Acta 1831: 1499–1508, 2013.
29. Ma X, Torbenson M, Hamad AR, Soloski MJ, Li Z. High-fat diet modulates non-CD1d-restricted natural killer T cells and regulatory T cells in mouse colon and exacerbates experimental colitis. Clin Exp Immunol 151: 130–138, 2008.
30. Martin TA, Jiang WG. Loss of tight junction barrier function and its role in cancer metastasis. Biochim Biophys Acta 1788: 872–891, 2009.
31. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and betacell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412–419, 1985.
32. Mizoshita T, Tsukamoto T, Inada KI, Hirano N, Tajika M, Nakamura T, Ban H, Tatematsu M. Loss of MUC2 expression correlates with progression along the adenoma-carcinoma sequence pathway as well as de novo carcinogenesis in the colon. Histol Histopathol 22: 251–260, 2007.
33. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011–2012. J Am Med Assoc 311: 806–814, 2014.
34. Park SY, Kim JS, Seo YR, Sung MK. Effects of diet-induced obesity on colitis-associated colon tumor formation in A/J mice. Int J Obes (Lond) 36: 273–280, 2012.
35. Percinel S, Savas B, Ensari A, Kuzu I, Kuzu MA, Bektas M, Cetinkaya H, Kursun N. Mucins in the colorectal neoplastic spectrum with reference to conventional and serrated adenomas. Turk J Gastroenterol 18: 230–238, 2007.
36. Perse M, Cerar A. Dextran sodium sulphate colitis mouse model: traps and tricks. J Biomed Biotechnol 2012: 718617, 2012.
37. Romero-Calvo I, Ocon B, Martinez-Moya P, Suarez MD, Zarzuelo A, Martinez-Augustin O, de Medina FS. Reversible Ponceau staining as a loading control alternative to actin in Western blots. Anal Biochem 401: 318–320, 2010.
38. Santarelli RL, Pierre F, Corpet DE. Processed meat and colorectal cancer: a review of epidemiologic and experimental evidence. Nutr Cancer 60: 131–144, 2008.
39. Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood) 233: 674–688, 2008.
40. Teixeira LG, Leonel AJ, Aguilar EC, Batista NV, Alves AC, Coimbra CC, Ferreira AV, de Faria AM, Cara DC, Alvarez Leite JI. The combination of high-fat diet-induced obesity and chronic ulcerative colitis reciprocally exacerbates adipose tissue and colon inflammation. Lipids Health Dis 10: 204, 2011.
41. van der Logt EM, Blokzijl T, van der Meer R, Faber KN, Dijkstra G. Westernized high-fat diet accelerates weight loss in dextran sulfate sodium-induced colitis in mice, which is further aggravated by supplementation of heme. J Nutr Biochem 24: 1159–1165, 2013.
42. Van der Sluis M, De Koning BA, De Bruijn AC, Velcich A, Meijerink JP, Van Goudoever JB, Buller HA, Dekker J, Van Seuningen I, Renes IB, Einerhand AW. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 131: 117–129, 2006.
43. Vargas AJ, Thompson PA. Diet and nutrient factors in colorectal cancer risk. Nutr Clin Pract 27: 613–623, 2012.
44. Velcich A, Yang W, Heyer J, Fragale A, Nicholas C, Viani S, Kucherlapati R, Lipkin M, Yang K, Augenlicht L. Colorectal cancer in mice genetically deficient in the mucin Muc 2. Science 295: 1726–1729, 2002.
45. Viennois E, Chen F, Laroui H, Baker MT, Merlin D. Dextran sodium sulfate inhibits the activities of both polymerase and reverse transcriptase: lithium chloride purification, a rapid and efficient technique to purify RNA. BMC Res Notes 6: 360, 2013.
46. Waldner MJ, Foersch S, Neurath MF. Interleukin-6–a key regulator of colorectal cancer development. Int J Biol Sci 8: 1248–1253, 2012.
47. Walsh MD, Clendenning M, Williamson E, Pearson SA, Walters RJ, Nagler B, Packenas D, Win AK, Hopper JL, Jenkins MA, Haydon AM, Rosty C, English DR, Giles GG, McGuckin MA, Young JP, Buchanan DD. Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype. Mod Pathol 26: 1642–1656, 2013.
48. Wang S, Liu Z, Wang L, Zhang X. NF-kappaB signaling pathway, inflammation and colorectal cancer. Cell Mol Immunol 6: 327–334, 2009.
49. Willett WC. Diet and cancer: an evolving picture. J Am Med Assoc 293: 233–234, 2005.